Our data strongly support an essential role for IFN-β signaling in preventing neurodegenerative pathology and suggest Ifnb–/– mice as a model for nonfamilial, sporadic neurodegenerative diseases, particularly PD and DLB, with potential for testing future therapies. This evidence concerns the gene IFNB1 and neurodegenerative disease.